AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells

Clinical trial NCT04169022 · COMPLETED

Trial details

NCT number: NCT04169022
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2019-07-10
Primary completion: 2023-10-02
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.